vs
Side-by-side financial comparison of Eastern Bankshares, Inc. (EBC) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
Eastern Bankshares, Inc. is the larger business by last-quarter revenue ($295.9M vs $164.7M, roughly 1.8× PTC THERAPEUTICS, INC.). Eastern Bankshares, Inc. runs the higher net margin — 22.1% vs -82.0%, a 104.0% gap on every dollar of revenue. On growth, Eastern Bankshares, Inc. posted the faster year-over-year revenue change (710.6% vs -22.7%). Over the past eight quarters, Eastern Bankshares, Inc.'s revenue compounded faster (38.6% CAGR vs -11.5%).
Eastern Bank is a bank based in Boston, Massachusetts. Before de-mutualizing in 2020, it was the oldest and largest mutual bank in the United States and the largest community bank in Massachusetts.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
EBC vs PTCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $164.7M |
| Net Profit | $65.3M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | — | -43.3% |
| Net Margin | 22.1% | -82.0% |
| Revenue YoY | 710.6% | -22.7% |
| Net Profit YoY | -34.4% | -104.8% |
| EPS (diluted) | $0.29 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $295.9M | — | ||
| Q4 25 | $37.5M | $164.7M | ||
| Q3 25 | $241.5M | $211.0M | ||
| Q2 25 | $244.9M | $178.9M | ||
| Q1 25 | $31.1M | $1.2B | ||
| Q4 24 | $216.5M | $213.2M | ||
| Q3 24 | $203.4M | $196.8M | ||
| Q2 24 | $154.0M | $186.7M |
| Q1 26 | $65.3M | — | ||
| Q4 25 | $99.5M | $-135.0M | ||
| Q3 25 | $106.1M | $15.9M | ||
| Q2 25 | $100.2M | $-64.8M | ||
| Q1 25 | $-217.7M | $866.6M | ||
| Q4 24 | $60.8M | $-65.9M | ||
| Q3 24 | $-6.2M | $-106.7M | ||
| Q2 24 | $26.3M | $-99.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | -43.3% | ||
| Q3 25 | 38.9% | 1.4% | ||
| Q2 25 | 41.0% | -19.5% | ||
| Q1 25 | -590.9% | 82.5% | ||
| Q4 24 | 33.3% | -76.2% | ||
| Q3 24 | -1.6% | -27.7% | ||
| Q2 24 | 24.7% | -21.5% |
| Q1 26 | 22.1% | — | ||
| Q4 25 | 265.6% | -82.0% | ||
| Q3 25 | 44.0% | 7.5% | ||
| Q2 25 | 40.9% | -36.3% | ||
| Q1 25 | -699.2% | 73.7% | ||
| Q4 24 | 28.1% | -30.9% | ||
| Q3 24 | -3.0% | -54.2% | ||
| Q2 24 | 17.1% | -53.1% |
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.48 | $-1.63 | ||
| Q3 25 | $0.53 | $0.20 | ||
| Q2 25 | $0.50 | $-0.83 | ||
| Q1 25 | $-1.08 | $10.04 | ||
| Q4 24 | $0.29 | $-0.85 | ||
| Q3 24 | $-0.03 | $-1.39 | ||
| Q2 24 | $0.16 | $-1.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $551.7M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.3B | $-205.3M |
| Total Assets | $30.6B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $551.7M | — | ||
| Q4 25 | $507.6M | $1.9B | ||
| Q3 25 | $703.4M | $1.7B | ||
| Q2 25 | $948.3M | $2.0B | ||
| Q1 25 | $609.0M | $2.0B | ||
| Q4 24 | $1.9B | $1.1B | ||
| Q3 24 | $1.7B | $1.0B | ||
| Q2 24 | $1.4B | $1.1B |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $-205.3M | ||
| Q3 25 | $3.8B | $-155.8M | ||
| Q2 25 | $3.7B | $-206.5M | ||
| Q1 25 | $3.6B | $-185.8M | ||
| Q4 24 | $3.6B | $-1.1B | ||
| Q3 24 | $3.7B | $-1.1B | ||
| Q2 24 | $3.0B | $-980.2M |
| Q1 26 | $30.6B | — | ||
| Q4 25 | $30.6B | $2.9B | ||
| Q3 25 | $25.5B | $2.6B | ||
| Q2 25 | $25.5B | $2.6B | ||
| Q1 25 | $25.0B | $2.7B | ||
| Q4 24 | $25.6B | $1.7B | ||
| Q3 24 | $25.5B | $1.8B | ||
| Q2 24 | $21.0B | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $432.4M | $-34.3M | ||
| Q3 25 | $157.1M | $-66.3M | ||
| Q2 25 | $123.9M | $-58.3M | ||
| Q1 25 | $47.3M | $870.1M | ||
| Q4 24 | $283.8M | $-30.0M | ||
| Q3 24 | $108.3M | $-77.0M | ||
| Q2 24 | $54.3M | $-71.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | — | $-78.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | — | -42.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 4.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.35× | — | ||
| Q3 25 | 1.48× | -4.17× | ||
| Q2 25 | 1.24× | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | 4.67× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.06× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
